{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:40:07Z","timestamp":1785372007125,"version":"3.55.0"},"reference-count":24,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,11,29]]},"DOI":"10.1536\/ihj.25-303","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T22:08:20Z","timestamp":1764367700000},"page":"1025-1028","source":"Crossref","is-referenced-by-count":2,"title":["Cardiac Angiosarcoma"],"prefix":"10.1536","volume":"66","author":[{"given":"Chu","family":"Chen","sequence":"first","affiliation":[{"name":"Central Laboratory, The First College of Clinical Medical Science, China Three Gorges University &amp; Yichang Central People&apos;s Hospital"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songlin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, The First College of Clinical Medical of Science, China Three Gorges University, Yichang Central People&apos;s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease"},{"name":"Department of Cardiology, The First College of Clinical Medical Science, China Three Gorges University &amp; Yichang Central People&apos;s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Central Laboratory, The First College of Clinical Medical Science, China Three Gorges University &amp; Yichang Central People&apos;s Hospital"},{"name":"Hubei Provincial Clinical Research Center for Ischemic Cardiovascular Disease"},{"name":"Hubei Key Laboratory of Ischemic Cardiovascular Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Luo L, Zhao W, Wang Y, Liu K. Cardiac angiosarcoma: a case report and review of the literature. Echocardiography 2021; 38: 2083-90.","DOI":"10.1111\/echo.15221"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chambergo-Michilot D, De la Cruz-Ku G, Sterner RM, Bra\u00f1ez-Condorena A, Guerra-Canchari P, Stulak J. Clinical characteristics, management, and outcomes of patients with primary cardiac angiosarcoma: a systematic review. J Cardiovasc Thorac Res 2023; 15: 1-8.","DOI":"10.34172\/jcvtr.2023.30531"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fang X, Zheng S. Primary cardiac angiosarcoma: a case report. J Int Med Res 2021; 49: 3000605211033261.","DOI":"10.1177\/03000605211033261"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Krishnan T, Pettersson G, Mukherjee R, Singhal N. Cardiac angiosarcoma: a diagnostic and therapeutic challenge. J Cardiol Cases 2020; 22: 90-3.","DOI":"10.1016\/j.jccase.2020.04.010"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Li FF, Zhou YJ, Yan H. Spontaneous Rupture and Thrombosis of the Right Atrium. Chin Med J (Engl) 2018; 131: 241-2.","DOI":"10.4103\/0366-6999.222329"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jang Y, Kim J, Shim JW, <i>et al<\/i>. Primary cardiac angiosarcoma: a prolonged response to surgical resection followed by concurrent chemoradiotherapy with docetaxel. Springerplus 2016; 5: 648.","DOI":"10.1186\/s40064-016-2248-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Young RJ, Natukunda A, Liti\u00e8re S, Woll PJ, Wardelmann E, van der Graaf WT. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. Eur J Cancer 2014; 50: 3178-86.","DOI":"10.1016\/j.ejca.2014.10.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Linfeng Q, Xingjie X, Henry D, Zhedong W, Hongfei X, Haige Z. Cardiac angiosarcoma: a case report and review of current treatment. Medicine (Baltimore) 2019; 98: e18193.","DOI":"10.1097\/MD.0000000000018193"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Fujisawa Y, Yoshino K, Fujimura T, <i>et al<\/i>. Cutaneous angiosarcoma: the Possibility of new treatment options especially for patients with large primary tumor. Front Oncol 2018; 8: 46.","DOI":"10.3389\/fonc.2018.00046"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Byeon S, Song HN, Kim HK, <i>et al<\/i>. A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma. Clin Sarcoma Res 2016; 6: 8.","DOI":"10.1186\/s13569-016-0048-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Penel N, Bui BN, Bay JO, <i>et al<\/i>. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 2008; 26: 5269-74.","DOI":"10.1200\/JCO.2008.17.3146"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suzuki T, Yamamoto Y, Sakamoto N, <i>et al<\/i>. Dramatic recovery from cardiovascular collapse: paclitaxel as an urgent treatment for primary cardiac angiosarcoma. Intern Med 2021; 60: 67-71.","DOI":"10.2169\/internalmedicine.5420-20"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yonekura S, Endo Y, Fujii H, Ishikawa M, Egawa G, Kabashima K. Clinical benefit of switching from paclitaxel to docetaxel or vice versa in patients with cutaneous angiosarcoma resistant to first taxane chemotherapy. J Dermatol 2023; 50: 1493-6.","DOI":"10.1111\/1346-8138.16873"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kumari N, Bhandari S, Ishfaq A, <i>et al<\/i>. Primary cardiac angiosarcoma: a review. Cureus 2023; 15: e41947.","DOI":"10.7759\/cureus.41947"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takenaka S, Hashimoto N, Araki N, <i>et al<\/i>. Eleven cases of cardiac metastases from soft-tissue sarcomas. Jpn J Clin Oncol 2011; 41: 514-8.","DOI":"10.1093\/jjco\/hyq246"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chugh R, Wathen JK, Maki RG, <i>et al<\/i>. Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model. J Clin Oncol 2009; 27: 3148-53.","DOI":"10.1200\/JCO.2008.20.5054"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ray-Coquard I, Italiano A, Bompas E, <i>et al<\/i>. Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF\/GETO). Oncologist 2012; 17: 260-6.","DOI":"10.1634\/theoncologist.2011-0237"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ray-Coquard IL, Domont J, Tresch-Bruneel E, <i>et al<\/i>. Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: a randomized phase II Trial. J Clin Oncol 2015; 33: 2797-802.","DOI":"10.1200\/JCO.2015.60.8505"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakamura Y, Toda K, Miyagawa S, <i>et al<\/i>. Surgical Resection and Pazopanib Treatment for Recurrent Cardiac Angiosarcoma. Clin Pathol 2019; 12: 2632010x19831261.","DOI":"10.1177\/2632010X19831261"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chi Y, Fang Z, Hong X, <i>et al<\/i>. Safety and efficacy of anlotinib, a multikinase angiogenesis Inhibitor, in patients with refractory metastatic soft-tissue sarcoma. Clin Cancer Res 2018; 24: 5233-8.","DOI":"10.1158\/1078-0432.CCR-17-3766"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gallois C, Landi M, Taieb J, <i>et al<\/i>. Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict the Efficacy of Immune Checkpoint Inhibitors. Clin Cancer Res 2023; 29: 3771-8.","DOI":"10.1158\/1078-0432.CCR-22-3964"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wang X, Wei J, Zeng Z, Cai J, Lu Z, Liu A. Primary pleural epithelioid angiosarcoma treated successfully with anti-PD-1 therapy: a rare case report. Medicine (Baltimore) 2021; 100: e27132.","DOI":"10.1097\/MD.0000000000027132"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zeng Z, Mei Z, Chen M, <i>et al<\/i>. Cadonilimab plus anlotinib effectively relieves rare cardiac angiosarcoma with multiple metastases: a case report and literature review. Clin Res Cardiol 2024; 113: 358-65.","DOI":"10.1007\/s00392-023-02251-y"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Aluthman U, Ashour MA, Bafageeh SW, <i>et al<\/i>. Minimally-invasive approach via percutaneous femoral cannulation for the resection of intra-cardiac masses: a single center experience in the Middle-East. J Cardiothorac Surg 2023; 18: 203.","DOI":"10.1186\/s13019-023-02295-1"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/6\/66_25-303\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:54:40Z","timestamp":1764388480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/6\/66_25-303\/_article"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.25-303","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"article-number":"25-303"}}